Menu Search
Equities

Fortis Healthcare Ltd

FORTIS:NSI

Fortis Healthcare Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)697.85
  • Today's Change9.85 / 1.43%
  • Shares traded3.83m
  • 1 Year change+91.19%
  • Beta0.8025
Data delayed at least 15 minutes, as of Nov 25 2024 10:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy4
Outperform8
Hold0
Sell1
Strong Sell0

Share price forecast in INR

The 12 analysts offering 12 month price targets for Fortis Healthcare Ltd have a median target of 711.00, with a high estimate of 725.00 and a low estimate of 550.00. The median estimate represents a 0.64% increase from the last price of 706.50.
High2.6%725.00
Med0.6%711.00
Low-22.2%550.00

Dividends

In 2024, Fortis Healthcare Ltd reported a dividend of 1.00 INR, equaling last years dividend. The 9 analysts covering the company expect dividends of 0.80 INR for the upcoming fiscal year, a decrease of 19.70%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in INR

On Nov 08, 2024, Fortis Healthcare Ltd reported 2nd quarter 2025 earnings of 3.13 per share. This result exceeded the 2.69 expectation of the one analyst covering the company and exceeded last year's 2nd quarter results by 39.11%.
The next earnings announcement is expected on Feb 05, 2025.
Average growth rate+12.52%
Fortis Healthcare Ltd reported annual 2024 earnings of 7.71 per share on May 23, 2024.
Average growth rate-903.94%
More ▼

Revenue history & estimates in INR

Fortis Healthcare Limited had 2nd quarter 2025 revenues of 19.88bn. This bettered the 19.75bn consensus of the 8 analysts covering the company. This was 19.97% above the prior year's 2nd quarter results.
Average growth rate+3.07%
Fortis Healthcare Limited had revenues for the full year 2024 of 68.93bn. This was 9.45% above the prior year's results.
Average growth rate+12.12%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.